PLE Prevention and Management of Kidney Disease in Diabetes
PLE Prevention and Management of Kidney Disease in Diabetes Heading link
Authors:
Kaitlin E. Miles, PharmD
Clinical Assistant Professor/Academic Detailing Pharmacist
Medication Review and Academic Detailing (MRAD)/Illinois ADVANCE
University of Illinois at Chicago College of Pharmacy
Learning Objectives Heading link
Learning Objectives:
At the completion of this activity, the participant will be able to:
- Review the pathophysiology and pathogenesis of the development of chronic kidney disease (CKD) in diabetes.
- Describe current recommendations for CKD in diabetes.
- Summarize the current evidence of sodium glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1RAs) in patients with CKD with or without diabetes.
- Develop a treatment plan for a patient with diabetes and CKD based on patient-specific factors.
Activity Information Heading link
| Number of Credits Hours | 1.0 contact hour | Fee: | $35.00 |
| Release Date: | August 3, 2022 | Expiration Date: | August 31, 2024 |